The contribution of the rostral ventromedial medulla to the antinociceptive effects of systemic morphine in restrained and unrestrained rats

Neuroscience

Volumn 87, Issue 1, 1998, Pages 123-133

  Mitchell, J M ^a   Lowe, D ^a   Fields, H L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Analgesia; Cholecystokinin; Morphine; RVM; Stress; Tail flick

Indexed keywords

CHOLECYSTOKININ; MORPHINE; OPIATE;

ANALGESIA; ANTINOCICEPTION; ARTICLE; HYPOTHESIS; LATENT PERIOD; PRIORITY JOURNAL; TAIL FLICK TEST; THALAMUS VENTRAL NUCLEUS;

ANALGESICS, OPIOID; ANIMALS; CHOLECYSTOKININ; MALE; MEDULLA OBLONGATA; MICROINJECTIONS; MORPHINE; PAIN; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; RESTRAINT, PHYSICAL; STRESS; TAIL;

EID: 0032581109     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00119-5     Document Type: Article

References (72)

1. Abols I. A., Basbaum A. I. Afferent connections of the rostral medulla of the cat: a neural substrate for midbrain-medullary interactions in the modulation of pain. J. comp. Neurol. 201:1981;285-297.
2. Appelbaum B. D., Holtzman S. G. Characterization of stress-induced potentiation of opioid effects in the rat. J. Pharmac. exp. Ther. 213:1984;555-565.
3. Azami J., Llewelyn M. B., Roberts M. H. The contribution of nucleus reticularis paragigantocellularis and nucleus raphe magnus to the analgesia produced by systemically administered morphine, investigated with the microinjection technique. Pain. 12:1982;229-246.
4. Baber N. S., Dourish C. T., Hill D. R. The role of CCK, caerulein, and CCK antagonists in nociception. Pain. 39:1989;307-328.
5. Basbaum A. I., Clanton C. H., Fields H. L. Three bulbospinal pathways from the rostral medulla of the cat: an autoradiographic study of pain modulating systems. J. comp. Neurol. 178:1978;209-224.
6. Basbaum A. I., Fields H. L. The origin of descending pathways in the dorsolateral funiculus of the spinal cord of the cat and rat: further studies in the anatomy of pain modulation. J. comp. Neurol. 187:1979;513-532.
7. Basbaum A. I., Fields H. L. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. A. Rev. Neurosci. 7:1984;309-338.
8. Bowker R. M., Westlund K. N., Coulter J. D. Origins of serotonergic projections to the spinal cord in the rat: an immunocytochemical-retrograde transport study. Brain Res. 226:1981;187-199.
9. Calcagnetti D. J., Fleetwood S. W., Holtzman S. G. Pharmacological profile of the potentiation of opioid analgesia by restraint stress. Pharmac. Biochem. Behav. 37:1990;193-199.
10. Cannon J. T., Lewis J. W., Weinberg V. E., Liebeskind J. C. Evidence for the independence of brainstem mechanisms mediating analgesia induced by morphine and two forms of stress. Brain Res. 269:1983;231-236.
11. Chance W. T. Autoanalgesia: opiate and non-opiate mechanisms. Neurosci. Biobehav. Rev. 4:1980;55-67.
12. Crawley J. N., Corwin R. L. Biological actions of cholecystokinin. Peptides. 15:1994;731-755.
13. Dahlstrom A., Fuxe K. I. Evidence for the existence of monoamine neurons in the central nervous system. II. Experimental demonstration of monoamines in the cell bodies of brain stem neurons. Acta physiol. scand. 62:1964;1-55.
14. Dickenson A. H., Oliveras J. L., Besson J. M. Role of the nucleus raphe magnus in opiate analgesia as studied by the microinjection technique in the rat. Brain Res. 170:1979;95-111.
15. Faris P. L., Komisaruk B. R., Watkins L. R., Mayer D. J. Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia. Science. 219:1983;310-312.
16. Fields H. L., Basbaum A. I. Brainstem control of spinal pain-transmission neurons. A. Rev. Physiol. 40:1978;217-248.
17. Fields H. L., Malick A., Burstein R. Dorsal horn projection targets of on and off cells in the rostral ventromedial medulla. J. Neurophysiol. 74:1995;1742-1759.
18. Gall C., Lauterbron J., Burks D., Seroogy K. Co-localization of enkephalin and cholecystokinin in discrete areas of rat brain. Brain Res. 403:1987;403-408.
19. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
20. Helmstetter F. J., Bellgowan P. S., Tershner S. A. Inhibition of the tail flick reflex following microinjection of morphine into the amygdala. NeuroReport. 4:1993;471-474.
21. Helmstetter F. J., Tershner S. A. Lesions of the periaqueductal gray and rostral ventromedial medulla disrupt antinociceptive but not cardiovascular aversive conditional responses. J. Neurosci. 14:1994;7099-7108.
22. Helmstetter F. J., Tershner S. A., Poore L. H., Bellgowan P. S. F. Nociceptive inhibition following opioid stimulation of the basolateral amygdala is expressed through the periaqueductal gray and rostral ventromedial medulla. Brain Res. 779:1998;104-118.
23. Holstege G. Direct and indirect pathways to lamina I in the medulla oblongata and spinal cord of the cat. Prog. Brain Res. 77:1988;47-94.
24. Hopkins D. A., Helstege G. Amygdaloid projections to the mesencephalon, pons and medulla oblongata in the cat. Expl Brain Res. 32:1978;529-547.
25. Irwin S., Houde R. W., Bennett D. R., Hendershot L. C., Seevers M. H. The effects of morphine, methadone, and meperidine on some reflex responses of spinal animals to nociceptive stimulation. J. Pharmac. exp. Ther. 101:1950;132-143.
26. Kelly S. J., Franklin K. B. J. Electrolytic raphe magnus lesions block analgesia induced by a stress-morphine interaction but not analgesia induced by morphine alone. Neurosci. Lett. 52:1984;147-152.
27. Kennett G. A., Joseph M. H. The functional importance of increased brain tryptophan in the serotonergic response to restraint stress. Neuropharmacology. 20:1981;39-43.
28. Kiefel J. M., Cooper M. L., Bodnar R. J. Serotonin receptor subtype antagonists in the medial ventral medulla inhibit mesencephalic opiate analgesia. Brain Res. 597:1992;331-338.
29. Kiefel J. M., Rossi G. C., Bodnar R. J. Medullary μ and δ opioid receptors modulate mesencephalic morphine analgesia in rats. Brain Res. 624:1993;151-161.
30. Kruger L., Saporta S. and Swanson L. W. (1995) Photographic Atlas of the Rat Brain, 1st edn. Cambridge University Press, Cambridge, U.K.
31. Lavigne G. J., Millington W. R., Mueller G. P. The CCK-A and CCK-B receptor antagonists, devazepide and L365,260, enhance morphine antinociception only in non-acclimated rats exposed to a novel environment. Neuropeptides. 21:1992;119-129.
32. Le Bars D. (1988) Serotonin and pain. In Neuronal Serotonin (eds Osborne N. M. and Hamon M.), pp. 171-226. John Wiley, New York.
33. Levine J. D., Murphy T., Seidenwurm D., Cortez A., Fields H. L. A study of the quantal (all-or-none) change in reflex latency produced by opiate analgesics. Brain Res. 201:1980;129-141.
34. Li Y., Han J. Cholecystokinin-octapeptide antagonizes morphine analgesia in periaqueductal gray of the rat. Brain Res. 480:1989;105-110.
35. Light A. R., Perl E. R. Reexamination of dorsal root projection to the spinal dorsal horn including observations on the differential termination of coarse and fine fibers. J. comp. Neurol. 186:1979;117-132.
36. Light A. R., Perl E. R. Spinal termination of functionally identified primary afferent neurons with slowly conducting myelinated fibers. J. comp. Neurol. 186:1979;133-150.
37. Lines C., Challenor J., Traub M. Cholecystokinin and anxiety in normal volunteers: an investigation of the anxiogenic properties of pentagastrin and reversal by the cholecystokinin receptor subtype B antagonist L-365,260. Br. J. clin. Pharmac. 39:1995;235-242.
38. Liu H., Chandler S., Beitz A. J., Shipley M. T., Behbehani M. M. Characterization of the effect of cholecystokinin (CCK) on neurons in the periaqueductal gray of the rat: immunocytochemical and in vivo and in vitro electrophysiological studies. Brain Res. 642:1994;83-94.
39. Lovick T. A., Robinson J. P. Substance P-immunoreactive and serotonin-containing neurones in the ventral brainstem of the cat. Neurosci. Lett. 36:1983;223-228.
40. Lovick T. A. Ventrolateral medullary lesions block the antinociceptive and cardiovascular responses elicited by stimulating the dorsal periaqueductal grey matter in rats. Pain. 21:1985;241-252.
41. Magnuson D. J., Gray T. S. Central nucleus of amygdala and bed nucleus of stria terminalis projections to serotonin or tyrosine hydroxylase immunoreactive cells in the dorsal and median raphe nucleus in the rat. Soc. Neurosci. Abstr. 16:1990;121.
42. Mantyh P. W., Hunt S. P. Evidence for cholecystokinin-like immunoreactive neurons in the rat medulla oblongata which project to the spinal cord. Brain Res. 291:1984;49-54.
43. Martin G. E., Papp N. L., Bacino C. B. Contralateral turning evoked by the intranigral microinjection of muscimol and other GABA agonists. Brain Res. 155:1978;297-312.
44. Martin G. F., Vertes R. P., Waltzer R. Spinal projections of the gigantocellular reticular formation in the rat. Evidence for projections from different areas to laminae I and II and lamina IX. Brain Res. 58:1985;154-162.
45. Mason P., Fields H. L. Axonal trajectories and terminations of on- and off-cells in the lower brainstem of the cat. J. comp. Neurol. 288:1989;185-207.
46. McDonald A. J. Morphology of peptide-containing neurons in the rat basolateral amygdaloid nucleus. Brain Res. 338:1985;186-191.
47. Milne R. J., Gamble G. D. Behavioral modification of bulbospinal serotonergic inhibition and morphine analgesia. Brain Res. 521:1990;167-174.
48. Morgan M. M., Fields H. L. Pronounced changes in the activity of nociceptive modulatory neurons in the rostral ventromedial medulla in response to prolonged thermal noxious stimuli. J. Neurophysiol. 72:1994;1161-1170.
49. Paxinos G. and Watson C. (1997) The Rat Brain in Stereotaxic Coordinates, 3rd edn. Academic, San Diego.
50. Pert A., Yaksh T. L. Sites of morphine induced analgesia in the primate brain: relation to pain pathways. Brain Res. 80:1974;135-140.
51. Potrebic S. B., Mason P., Fields H. L. The density and distribution of serotonergic appositions onto identified neurons in the rat rostral ventromedial medulla. J. Neurosci. 15:1995;3273-3283.
52. Price J. L., Amaral D. G. An autoradiographic study of the projections of the central nucleus of the monkey amygdala. J. Neurosci. 1:1981;1242-1259.
53. Proudfit H. K., Anderson E. G. Morphine analgesia: blockade by raphe magnus lesions. Brain Res. 98:1975;612-618.
54. Proudfit H. K. Reversible innactivation of raphe magnus neurons: effects on nociceptive threshold and morphine-induced analgesia. Brain Res. 201:1980;459-464.
55. Proudfit H. K. Time-course of alterations in morphine-induced analgesia and nociceptive threshold following medullary raphe lesions. Neuroscience. 6:1981;945-951.
56. Randic M., Yu H. H. Effects of 5-hydroxytryptamine and bradykinin in cat dorsal horn neurones activated by noxious stimuli. Brain Res. 111:1976;197-203.
57. Roberts G. W., Woodhams P. L., Polak J. M., Crow T. J. Distribution of neuropeptides in the limbic system of the rat: the amygdaloid complex. Neuroscience. 7:1982;99-131.
58. Roychowdhury S. M., Fields H. L. Endogenous opioids acting at a medullary μ-opioid receptor contribute to the behavioral antinociception produced by GABA antagonism in the midbrain periaqueductal gray. Neuroscience. 74:1996;863-872.
59. Ruda M. A., Allen B., Gobel S. Ultrastructural analysis of medial brain stem afferents to the superficial dorsal horn. Brain Res. 205:1981;175-180.
60. Skagerberg G., Bjorklund A. Topographic principles in the spinal projections of serotonergic and non-serotonergic brainstem neurons in the rat. Neuroscience. 15:1985;445-480.
61. Solomon R. E., Gebhart G. F. Mechanisms of effects of intrathecal serotonin on nociception and blood pressure in rats. J. Pharmac. exp. Ther. 245:1988;905-912.
62. Urban M. O., Smith D. J. Nuclei within the rostral ventromedial medulla mediating morphine antinociception from the periaqueductal gray. Brain Res. 652:1994;9-16.
63. Van Bockstaele E. J., Aston-Jones G., Pieribone V. A., Ennis M., Shipley M. T. Subregions of the periaqueductal gray topographically innervate the rostral ventral medulla in the rat. J. comp. Neurol. 309:1991;305-327.
64. Vanegas H., Barbaro N. M., Fields H. L. Tail-flick related activity in medullospinal neurons. Brain Res. 321:1984;135-141.
65. Watkins L. R., Cobelli D. A., Mayer D. J. Classical conditioning of front paw and hind paw footshock induced analgesia (FSIA): naloxone reversibility and descending pathways. Brain Res. 243:1982;119-132.
66. Watkins L. R., Young E. G., Kinscheck I. B., Mayer D. J. The neural basis of footshock analgesia: the role of specific ventral medullary nuclei. Brain Res. 276:1983;305-315.
67. Wiertelak E. P., Maier S. F., Watkins L. R. Cholecystokinin antianalgesia: safety cues abolish morphine analgesia. Science. 256:1992;830-833.
68. Yaksh T. L., Rudy T. A. Analgesia mediated by a direct spinal action of narcotics. Science. 192:1976;1357-1358.
69. Yaksh T. L., Plant R. L., Rudy T. A. Studies on the antagonism by raphe lesions of the antinociceptive action of systemic morphine. Eur. J. Pharmac. 41:1977;399-408.
70. Yaksh T. L. Direct evidence that spinal serotonin and noradrenaline terminals mediate the spinal antinociceptive effects of morphine in the periaqueductal grey. Brain Res. 160:1979;180-185.
71. Yaksh T. L. (1993) The spinal actions of opioids. In Handbook of Experimental Pharmacology, Opioids II (ed. Herz A.), pp. 53-90. Springer, Berlin.
72. Young E. G., Watkins L. R., Mayer D. J. Comparison of the effects of ventral medullary lesions on systemic and microinjection morphine analgesia. Brain Res. 290:1984;119-129.